Steven Cohen's position in Adma Biologics is currently worth $1.57 Million. That's 0.00% of their equity portfolio (795th largest holding). The first Adma Biologics trade was made in Q1 2020. Since then Steven Cohen bought shares two more times and sold shares on three occasions. The stake costed the investor $905 Thousand, netting the investor a gain of 74% so far.